Editorial ArticleDevelopment of a Luminex xMAP® Assay to Detect Amyloid β Oligomers in Alzheimer’s Disease Cerebrospinal Fluid
Product NewsLuminex Receives FDA Clearance to Add New Clinical Targets and Additional Sample Type for Use with xTAG® Gastrointestinal Pathogen Panel
Product NewsLuminex Corporation Announces European Unveiling of its New Sample-to-Answer System at ECCMID
Product NewsLuminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement
Product NewsLuminex Corporation Receives U.S. FDA Clearance for MAGPIX® Instrument with Novel xTAG® Gastrointestinal Pathogen Panel